Catalyst Pharmaceuticals, Inc. (CPRX)
NASDAQ: CPRX · Real-Time Price · USD
23.23
-0.16 (-0.68%)
At close: Mar 13, 2026, 4:00 PM EDT
23.71
+0.48 (2.07%)
After-hours: Mar 13, 2026, 7:45 PM EDT

Catalyst Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,8372,8592,5231,8011,958697
Market Cap Growth
7.84%13.35%40.10%-8.03%180.80%101.15%
Enterprise Value
2,1312,1532,0081,6661,663509.89
Last Close Price
23.2323.3420.8716.8118.606.77
PE Ratio
13.8313.8915.9326.6824.8018.30
Forward PE
12.3615.4815.3814.1314.9813.97
PEG Ratio
1.06-----
PS Ratio
4.824.855.134.529.144.95
PB Ratio
2.983.003.474.646.523.37
P/TBV Ratio
3.103.113.584.936.903.53
P/FCF Ratio
13.6013.7110.5412.5616.8811.75
P/OCF Ratio
13.6013.7010.5212.5416.8711.55
EV/Sales Ratio
3.623.654.084.187.763.62
EV/EBITDA Ratio
7.217.288.6213.9216.139.70
EV/EBIT Ratio
8.278.3510.2919.1916.339.73
EV/FCF Ratio
10.2110.328.3911.6214.338.59
Debt / Equity Ratio
0.000.000.000.010.010.02
Debt / EBITDA Ratio
0.010.010.010.030.040.07
Debt / FCF Ratio
0.010.010.010.020.030.07
Net Debt / Equity Ratio
-0.74-0.74-0.71-0.35-0.98-0.91
Net Debt / EBITDA Ratio
-2.39-2.39-2.21-1.12-2.86-3.56
Net Debt / FCF Ratio
-3.39-3.39-2.15-0.94-2.54-3.16
Asset Turnover
0.600.600.740.940.700.65
Inventory Turnover
3.083.083.914.634.693.50
Quick Ratio
5.685.684.832.515.367.31
Current Ratio
6.086.085.172.885.577.76
Return on Equity (ROE)
25.49%25.49%29.38%20.75%32.76%20.98%
Return on Assets (ROA)
19.93%19.93%22.38%15.51%26.34%18.26%
Return on Invested Capital (ROIC)
84.57%84.57%62.98%47.52%413.20%161.01%
Return on Capital Employed (ROCE)
30.55%30.55%34.70%24.38%38.52%27.55%
Earnings Yield
7.55%7.20%6.28%3.75%4.03%5.47%
FCF Yield
7.35%7.30%9.48%7.96%5.93%8.51%
Buyback Yield / Dilution
0.43%0.43%-6.10%-0.10%-0.12%1.17%
Updated Feb 25, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q